Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dani Brunner

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Developmental Psychobiology|January 30, 2003
Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout miceAron Weller, Ana Christina Leguisamo, Lorraine Towns, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR LigandsOluseye K Onajole, J Brek Eaton, Ronald J Lukas, et al.
Plos Currents|April 19, 2012
HD mouse models reveal clear deficits in learning to perform a simple instrumental responseStephen Oakeshott, Russell G Port, Jane Cummins-Sutphen, et al.
Plos Currents|November 26, 2013
Deficits in a Simple Visual Go/No-go Discrimination Task in Two Mouse Models of Huntington's DiseaseStephen Oakeshott, Andrew Farrar, Russell Port, et al.
ACS Chemical Neuroscience|April 2, 2016
Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part IIIOluseye K Onajole, Gian Paolo Vallerini, J Brek Eaton, et al.
Journal of Medicinal Chemistry|June 4, 2013
Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesisHendra Gunosewoyo, Andrew Midzak, Irina N Gaisina, et al.
Journal of Medicinal Chemistry|October 25, 2012
Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part IILi-Fang Yu, J Brek Eaton, Allison Fedolak, et al.
Plos Currents|December 10, 2015
A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z_Q175 KI mouse models of Huntington's diseaseStephen Oakeshott, Russell Port, Jane Cummins-Sutphen, et al.
Journal of Medicinal Chemistry|December 14, 2011
Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activityLi-Fang Yu, Werner Tückmantel, J Brek Eaton, et al.
European Journal of Medicinal Chemistry|September 19, 2016
Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonistsHan-Kun Zhang, J Brek Eaton, Allison Fedolak, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Developmental Psychobiology|January 30, 2003
Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout miceAron Weller, Ana Christina Leguisamo, Lorraine Towns, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR LigandsOluseye K Onajole, J Brek Eaton, Ronald J Lukas, et al.
Plos Currents|April 19, 2012
HD mouse models reveal clear deficits in learning to perform a simple instrumental responseStephen Oakeshott, Russell G Port, Jane Cummins-Sutphen, et al.
Plos Currents|November 26, 2013
Deficits in a Simple Visual Go/No-go Discrimination Task in Two Mouse Models of Huntington's DiseaseStephen Oakeshott, Andrew Farrar, Russell Port, et al.
ACS Chemical Neuroscience|April 2, 2016
Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part IIIOluseye K Onajole, Gian Paolo Vallerini, J Brek Eaton, et al.
Journal of Medicinal Chemistry|June 4, 2013
Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesisHendra Gunosewoyo, Andrew Midzak, Irina N Gaisina, et al.
Journal of Medicinal Chemistry|October 25, 2012
Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part IILi-Fang Yu, J Brek Eaton, Allison Fedolak, et al.
Plos Currents|December 10, 2015
A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z_Q175 KI mouse models of Huntington's diseaseStephen Oakeshott, Russell Port, Jane Cummins-Sutphen, et al.
Journal of Medicinal Chemistry|December 14, 2011
Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activityLi-Fang Yu, Werner Tückmantel, J Brek Eaton, et al.
European Journal of Medicinal Chemistry|September 19, 2016
Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonistsHan-Kun Zhang, J Brek Eaton, Allison Fedolak, et al.
Pageof 4